<DOC>
	<DOCNO>NCT01135667</DOCNO>
	<brief_summary>All patient undergo elective sub-acute PCI screen MULTIPLATE test clopidogrel low-responsiveness receive 600 mg clopidogrel day . A cut value previously establish . Only low-responders Multiplate value cut value include study . The patient randomize either clopidogrel 150 mg daily Prasugrel 10 mg ( age &gt; 75 og bodyweight &lt; 60 kg 5 mg ) daily 30 day procedure . Follow 30 day PCI another MULTIPLATE test perform . Primary endpoint : Platelet inhibition ( MULTIPLATE ) 30 day intensify antiplatelet therapy . Clinical endpoint bleed complication ( GUSTO , TIMI ) treatment , major adverse cardiac event ( MACE ) 30 day collect report study size allow formal statistical analysis The study end 30 day follow visit patient continue clopidogrel 75 mg daily another 11 month ( study relate )</brief_summary>
	<brief_title>Prasugrel Versus Double Dose Clopidogrel Treat Clopidogrel Low-responsiveness After PCI</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Prasugrel Hydrochloride</mesh_term>
	<criteria>PCI stenting Multiplate hepADP &gt; 70 U despite clopidogrel load need vit K antagonist woman childbearing potential breastfeeding woman Planned surgery within 6 month Intolerance clopidogrel , prasugrel aspirin previous stroke</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>clopidogrel</keyword>
	<keyword>prasugrel</keyword>
	<keyword>low responder</keyword>
	<keyword>multiplate</keyword>
	<keyword>verify</keyword>
</DOC>